9月 2023, <>
英文版
加利福尼亚州红木城,09年2023月31日(环球通讯社)--Soleno Therapeutics,Inc.(Soleno)(纳斯达克股票代码:SLNO)...查看全文
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-018228 Size: 4 KB 网页链接
$Soleno Therapeutics(SLNO)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-21-124659 Act: 34 Size: 1 MB 网页链接
$Soleno Therapeutics(SLNO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-21-116788 Act: 34 Size: 177 KB 网页链接
$Soleno Therapeutics(SLNO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-21-073172 Act: 34 Size: 166 KB 网页链接
$Soleno Therapeutics(SLNO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-21-067562 Act: 34 Size: 236 KB 网页链接
$Soleno Therapeutics(SLNO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-21-010569 Act: 34 Size: 9 MB 网页链接
$Soleno Therapeutics(SLNO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-21-023865 Act: 34 Size: 99 KB 网页链接
$Soleno Therapeutics(SLNO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-21-021781 Act: 34 Size: 51 KB 网页链接
$Soleno Therapeutics(SLNO)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-000525 Act: 33 Size: 1 KB 网页链接
$Soleno Therapeutics(SLNO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-21-029875 Act: 34 Size: 183 KB 网页链接